Literature DB >> 22693404

Estrogen Receptor Negative Breast Cancer in India: Do We Really Have Higher Burden of this Subtype?

Suraj Manjunath, Jyothi S Prabhu, Rohini Kaluve, Marjorie Correa, T S Sridhar.   

Abstract

ER negative and Triple negative breast cancers carry a poorer prognosis and are not amenable to hormone therapy. It has been previously observed that Indian patients with breast cancer have a higher tendency to have these tumours. Whether this is due to inherent biological differences in the tumours of our patients is a matter of much debate. We have analysed 250 patients of breast cancer for hormone receptor status, compared them with western series, and attempted to support the hypothesis that the higher ER negativity and triple negativity is indeed due to different tumour biology.

Entities:  

Keywords:  Breast cancer; Estrogen receptor; Triple negative

Year:  2011        PMID： 22693404      PMCID： PMC3244189          DOI： 10.1007/s13193-011-0072-8

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN： 0975-7651


  11 in total

1.  Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe. Documentation of poor reliability and identification of insufficient microwave antigen retrieval time as a major contributory element of unreliable assays.

Authors:  A Rhodes; B Jasani; A J Balaton; D M Barnes; E Anderson; L G Bobrow; K D Miller
Journal:  Am J Clin Pathol       Date:  2001-01       Impact factor: 2.493

2.  High incidence of oestrogen receptor negative progesterone receptor positive phenotype in Indian breast cancer: fact or fiction?

Authors:  Sanjay Navani; Anita S Bhaduri
Journal:  Indian J Pathol Microbiol       Date:  2005-04       Impact factor: 0.740

3.  Clinical features and prognostic factors of early breast cancer at a major cancer center in North India.

Authors:  Vinod Raina; Manisha Bhutani; Rajeev Bedi; Atul Sharma; Suryanarayana V Deo; Nootan K Shukla; Bidhu Kalyan Mohanti; Goura K Rath
Journal:  Indian J Cancer       Date:  2005 Jan-Mar       Impact factor: 1.224

4.  Minimum formalin fixation time for consistent estrogen receptor immunohistochemical staining of invasive breast carcinoma.

Authors:  Neal S Goldstein; Monica Ferkowicz; Eva Odish; Anju Mani; Farnaz Hastah
Journal:  Am J Clin Pathol       Date:  2003-07       Impact factor: 2.493

5.  Comparison of immunoexpression of 2 antibodies for estrogen receptors (1D5 and 6F11) in breast carcinomas using different antigen retrieval and detection methods.

Authors:  J Vassallo; G A Pinto; J M Alvarenga; L C Zeferino; C A Chagas; K Metze
Journal:  Appl Immunohistochem Mol Morphol       Date:  2004-06

6.  Hormone receptor status of breast cancer in India: a study of 798 tumours.

Authors:  S B Desai; M T Moonim; A K Gill; R S Punia; K N Naresh; R F Chinoy
Journal:  Breast       Date:  2000-10       Impact factor: 4.380

7.  Risk factors according to estrogen receptor status of breast cancer patients in Trivandrum, South India.

Authors:  Subhojit Dey; Paolo Boffetta; Anitha Mathews; Paul Brennan; Amr Soliman; Aleyamma Mathew
Journal:  Int J Cancer       Date:  2009-10-01       Impact factor: 7.396

8.  Hormone receptors over the last 8 years in a cancer referral center in India: what was and what is?

Authors:  Tanuja Shet; Atin Agrawal; Mandar Nadkarni; Mahendra Palkar; Rohini Havaldar; Vani Parmar; Rajendra Badwe; R F Chinoy
Journal:  Indian J Pathol Microbiol       Date:  2009 Apr-Jun       Impact factor: 0.740

9.  Immunohistochemical evaluation of hormone receptors in breast cancer: which scoring system is suitable for highly sensitive procedures?

Authors:  Shinobu Umemura; Johbu Itoh; Hitoshi Itoh; Akihiko Serizawa; Yuki Saito; Yasuhiro Suzuki; Yutaka Tokuda; Tomoo Tajima; R Yoshiyuki Osamura
Journal:  Appl Immunohistochem Mol Morphol       Date:  2004-03

10.  Epidemiology and patterns of care for invasive breast carcinoma at a community hospital in Southern India.

Authors:  Sambasivaiah Kuraparthy; Kumaraswamy M Reddy; Lakshmi Amancharla Yadagiri; Mutheeswaraiah Yutla; Phanindra Bobbidi Venkata; Sarma V S Kadainti; Ramasubba P V Reddy
Journal:  World J Surg Oncol       Date:  2007-05-23       Impact factor: 2.754
View more
  11 in total

Review 1.  Preventing breast cancer in LMICs via screening and/or early detection: The real and the surreal.

Authors:  Subhojit Dey
Journal:  World J Clin Oncol       Date:  2014-08-10

2.  Patterns of Care of Breast Cancer Patients in a Rural Cancer Center in Western India.

Authors:  Bhagwan M Nene; Farida Selmouni; Manoj Lokhande; Sanjay J Hingmire; Richard Muwonge; Kasturi Jayant; Rengaswamy Sankaranarayanan
Journal:  Indian J Surg Oncol       Date:  2018-04-11

3.  Hormone-receptor expression and survival patterns in operated cases of female invasive ductal breast carcinoma in Kerala: a retrospective cohort study.

Authors:  Ajith Vettuparambil; Ravindran Chirukandath; Terence B Culas; Sajna Mathumkunnath Vijayan; Gautham Rajan; Sathidevi Vadakkepura Kuttappan
Journal:  World J Surg Oncol       Date:  2015-04-23       Impact factor: 2.754

Review 4.  Reduction of breast cancer relapses with perioperative non-steroidal anti-inflammatory drugs: new findings and a review.

Authors:  Michael Retsky; Romano Demicheli; William J M Hrushesky; Patrice Forget; Marc De Kock; Isaac Gukas; Rick A Rogers; Michael Baum; Vikas Sukhatme; Jayant S Vaidya
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

5.  A Majority of Low (1-10%) ER Positive Breast Cancers Behave Like Hormone Receptor Negative Tumors.

Authors:  Jyothi S Prabhu; Aruna Korlimarla; Krisha Desai; Annie Alexander; Rohini Raghavan; Ce Anupama; Nandini Dendukuri; Suraj Manjunath; Marjorrie Correa; N Raman; Anjali Kalamdani; Msn Prasad; K S Gopinath; B S Srinath; T S Sridhar
Journal:  J Cancer       Date:  2014-01-23       Impact factor: 4.207

6.  Estrogen and progesterone receptor status in breast cancer: a cross-sectional study of 450 women in Kerala, South India.

Authors:  Gautham Rajan; Terence B Culas; P S Jayalakshmy
Journal:  World J Surg Oncol       Date:  2014-04-24       Impact factor: 2.754

7.  Establishment and characterization of two primary breast cancer cell lines from young Indian breast cancer patients: mutation analysis.

Authors:  Santhi Latha Pandrangi; Sarangadhara Appala Raju Bagadi; Navin Kumar Sinha; Manoj Kumar; Rima Dada; Meena Lakhanpal; Abha Soni; Shreshtha Malvia; Sheeba Simon; Chintamani Chintamani; Ravindar Singh Mohil; Dinesh Bhatnagar; Sunita Saxena
Journal:  Cancer Cell Int       Date:  2014-02-05       Impact factor: 5.722

Review 8.  Improving accuracy of breast cancer biomarker testing in India.

Authors:  Tanuja Shet
Journal:  Indian J Med Res       Date:  2017-10       Impact factor: 2.375

9.  Meta-Analysis of Prevalence of Triple-Negative Breast Cancer and Its Clinical Features at Incidence in Indian Patients With Breast Cancer.

Authors:  Apurv Kulkarni; Devaki A Kelkar; Nidhi Parikh; Lingadahalli S Shashidhara; Chaitanyanand B Koppiker; Madhura Kulkarni
Journal:  JCO Glob Oncol       Date:  2020-07

10.  Estrogen receptor, Progesterone receptor, and human epidermal growth factor receptor-2 status in breast cancer: A retrospective study of 5436 women from a regional cancer center in South India.

Authors:  Rekha Vijay Kumar; Dipti Panwar; Usha Amirtham; Chennagiri Srinivasmurthy Premalata; Champaka Gopal; Suma Mysore Narayana; Geetha Vikram Patil Okaly; K C Lakshmaiah; S Krishnamurthy
Journal:  South Asian J Cancer       Date:  2018 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.